POLEM Trial: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer: A phase III randomised study
GA ID:
Agency:
Department of Health and Aged Care
Publish Date:
5-Feb-2020
Category:
Health and Medical Research
Grant Term:
1-Feb-2020
to
31-Jan-2025
Value (AUD):
$981,312.50
Recipient Name:
University of Sydney
Last Updated:
5-Feb-2020 12:34 pm (ACT Local Time)